These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications. Bikos V; Darzentas N; Hadzidimitriou A; Davis Z; Hockley S; Traverse-Glehen A; Algara P; Santoro A; Gonzalez D; Mollejo M; Dagklis A; Gangemi F; Bosler DS; Bourikas G; Anagnostopoulos A; Tsaftaris A; Iannitto E; Ponzoni M; Felman P; Berger F; Belessi C; Ghia P; Papadaki T; Dogan A; Degano M; Matutes E; Piris MA; Oscier D; Stamatopoulos K Leukemia; 2012 Jul; 26(7):1638-46. PubMed ID: 22222599 [TBL] [Abstract][Full Text] [Related]
9. Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis. Watkins AJ; Huang Y; Ye H; Chanudet E; Johnson N; Hamoudi R; Liu H; Dong G; Attygalle A; McPhail ED; Law ME; Isaacson PG; de Leval L; Wotherspoon A; Du MQ J Pathol; 2010 Mar; 220(4):461-74. PubMed ID: 20077527 [TBL] [Abstract][Full Text] [Related]
10. A restricted IGHV gene repertoire in splenic marginal zone lymphoma is associated with autoimmune disorders. Brisou G; Verney A; Wenner T; Baseggio L; Felman P; Callet-Bauchu E; Coiffier B; Berger F; Salles G; Traverse-Glehen A Haematologica; 2014 Oct; 99(10):e197-8. PubMed ID: 24997147 [No Abstract] [Full Text] [Related]
11. Splenic marginal-zone lymphoma: one or more entities? A histologic, immunohistochemical, and molecular study of 42 cases. Papadaki T; Stamatopoulos K; Belessi C; Pouliou E; Parasi A; Douka V; Laoutaris N; Fassas A; Anagnostopoulos A; Anagnostou D Am J Surg Pathol; 2007 Mar; 31(3):438-46. PubMed ID: 17325486 [TBL] [Abstract][Full Text] [Related]
12. Immunoarchitectural patterns in splenic marginal zone lymphoma: correlations with chromosomal aberrations, IGHV mutations, and survival. A study of 76 cases. Traverse-Glehen A; Bachy E; Baseggio L; Callet-Bauchu E; Gazzo S; Verney A; Hayette S; Jallades L; Ffrench M; Salles G; Coiffier B; Felman P; Berger F Histopathology; 2013 May; 62(6):876-93. PubMed ID: 23611359 [TBL] [Abstract][Full Text] [Related]
14. [IGHV mutational statue in patients with splenic marginal zone lymphoma]. Yang WJ; Yu Z; Lyu R; Li ZJ; Li H; Xiong WJ; Yi SH; Liu W; Qiu LG Zhonghua Xue Ye Xue Za Zhi; 2016 Sep; 37(9):774-778. PubMed ID: 27719720 [TBL] [Abstract][Full Text] [Related]
15. Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities. Gailllard B; Cornillet-Lefebvre P; Le QH; Maloum K; Pannetier M; Lecoq-Lafon C; Grange B; Jondreville L; Michaux L; Nadal N; Ittel A; Luquet I; Struski S; Lefebvre C; Gaillard JB; Lafage-Pochitaloff M; Balducci E; Penther D; Barin C; Collonge-Rame MA; Jimenez-Poquet M; Richebourg S; Lemaire P; Defasque S; Radford-Weiss I; Bidet A; Susin SA; Nguyen-Khac F; Chapiro E; Br J Haematol; 2021 Apr; 193(1):72-82. PubMed ID: 33314017 [TBL] [Abstract][Full Text] [Related]
16. CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases. Baseggio L; Traverse-Glehen A; Petinataud F; Callet-Bauchu E; Berger F; Ffrench M; Couris CM; Thieblemont C; Morel D; Coiffier B; Salles G; Felman P Haematologica; 2010 Apr; 95(4):604-12. PubMed ID: 20015887 [TBL] [Abstract][Full Text] [Related]
18. High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma. Fresquet V; Robles EF; Parker A; Martinez-Useros J; Mena M; Malumbres R; Agirre X; Catarino S; Arteta D; Osaba L; Mollejo M; Hernandez-Rivas JM; Calasanz MJ; Daibata M; Dyer MJ; Prosper F; Vizcarra E; Piris MÁ; Oscier D; Martinez-Climent JA Br J Haematol; 2012 Sep; 158(6):712-26. PubMed ID: 22816737 [TBL] [Abstract][Full Text] [Related]
19. Analysis of VH genes in marginal zone lymphoma reveals marked heterogeneity between splenic and nodal tumors and suggests the existence of clonal selection. Traverse-Glehen A; Davi F; Ben Simon E; Callet-Bauchu E; Felman P; Baseggio L; Gazzo S; Thieblemont C; Charlot C; Coiffier B; Berger F; Salles G Haematologica; 2005 Apr; 90(4):470-8. PubMed ID: 15820942 [TBL] [Abstract][Full Text] [Related]
20. A gene is known by the company it keeps: enrichment of TNFAIP3 gene aberrations in MALT lymphomas expressing IGHV4-34 antigen receptors. Agathangelidis A; Xochelli A; Stamatopoulos K J Pathol; 2017 Dec; 243(4):403-406. PubMed ID: 28892161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]